A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis
Table 3
WOMAC total score changes at week 12 compared to the baseline.
Group
Control group
Group A
Group B
N
24
31
27
Mean±SD
- 13.1±12.8
- 16.3±11.6
- 20.1±9.5
p value (compared to the baseline)
<0.001
<0.001
<0.001
p value (paired-wise comparison)
Group B vs. control group: p= 0.04
p value (Kruskal-Wallis test to compare between 3 groups)
